Spots Global Cancer Trial Database for warfarin
Every month we try and update this database with for warfarin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters | NCT00024297 | Thromboembolism | warfarin | 16 Years - | National Cancer Institute (NCI) | |
| Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | NCT01130025 | Venous Thromboe... | Warfarin Innohep® | 18 Years - | LEO Pharma | |
| Biological Effect of Warfarin on Pancreatic Cancer | NCT03536208 | Pancreatic Canc... | Warfarin | 18 Years - | University of Texas Southwestern Medical Center | |
| A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin | NCT01388335 | Solid Tumor Lymphoma, Malig... | warfarin enzastaurin | 18 Years - 60 Years | Eli Lilly and Company | |
| A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors | NCT02422589 | ALK-positive Ad... | ceritinib warfarin midazolam | 18 Years - | Novartis | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin | NCT01388335 | Solid Tumor Lymphoma, Malig... | warfarin enzastaurin | 18 Years - 60 Years | Eli Lilly and Company | |
| BAY73-4506 Probe Substrate Study | NCT01287598 | Neoplasms | Regorafenib (St... Warfarin Omeprazole Midazolam Rosiglitazone | 18 Years - | Bayer | |
| A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors | NCT02422589 | ALK-positive Ad... | ceritinib warfarin midazolam | 18 Years - | Novartis | |
| Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | NCT00014352 | Prostate Cancer Thromboembolism | docetaxel doxorubicin hyd... estramustine ph... ketoconazole warfarin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | NCT00004054 | Prostate Cancer | bicalutamide estramustine ph... etoposide flutamide paclitaxel Luteinizing hor... Radiation thera... warfarin | 18 Years - | Radiation Therapy Oncology Group | |
| A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors | NCT01340846 | Cancer | Warfarin Ketoconazole Gemfibrozil GSK2118436 150m... GSK2118436 75mg | 18 Years - | GlaxoSmithKline | |
| Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors | NCT00091299 | Unspecified Adu... | warfarin | 18 Years - | Jonsson Comprehensive Cancer Center | |
| PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates | NCT04887194 | Advanced Solid ... | Sitravatinib Warfarin Dextromethorpha... Midazolam Digoxin Rosuvastatin Nivolumab | 18 Years - | Mirati Therapeutics Inc. | |
| Biological Effect of Warfarin on Pancreatic Cancer | NCT03536208 | Pancreatic Canc... | Warfarin | 18 Years - | University of Texas Southwestern Medical Center | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates | NCT01911728 | Pharmacokinetic... Castration Resi... | MDV3100 Pioglitazone Warfarin Omeprazole Midazolam | 18 Years - | Astellas Pharma Inc | |
| The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis | NCT00216866 | Embolism and Th... | Dalteparin Warfarin | 18 Years - | Lawson Health Research Institute | |
| Pharmacokinetic Drug-Drug Interaction Study of Rucaparib | NCT02740712 | Neoplasms | Caffeine Warfarin Omeprazole Midazolam digoxin Vitamin K Rucaparib | 18 Years - | pharmaand GmbH | |
| The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis | NCT00216866 | Embolism and Th... | Dalteparin Warfarin | 18 Years - | Lawson Health Research Institute | |
| Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | NCT01130025 | Venous Thromboe... | Warfarin Innohep® | 18 Years - | LEO Pharma |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
